Research powered by data
The Data for Research and Development Programme is driving secure, transparent and ethical use of NHS health data to improve care and save lives.
Receive our updates
Email [email protected] to receive updates about the Data for Research and Development programme.
Data is critical for the NHS to improve patient care. We are investing £175million in the Data for Research and Development Programme to transform how we use health data.
The programme is enabling transformative research to improve patient outcomes and driving a major shift from data sharing to a data access model, increasing data security, privacy, and transparency. This page shows the impact of the programme and the services it supports.
Our services
Supporting the research lifecycle
We are supporting the entire research life cycle, supporting effective research that benefits patients.
Applying to access data
Researchers and organisations must apply to access data and meet strict governance standards. Find out more about the Data Access Request Service process.
How we are listening to the public
We are committed to building public understand and trust through transparent communications and involving them in decisions about how health data is used.
News, case studies, blogs and videos
Our experts explain how we are using data to drive research and improve NHS and care services.
How NHS England Secure Data Environment is accelerating healthcare research
Read how the NHS England Secure Data Environment is powering life-saving research and treatments.
Collaborating for the future of health data
Hilary Fanning, SRO for the NHS England Data for Research and Development Programme, describes how we are transforming data use to drive innovation.
Research, powered by NHS data
Rebecca Cosgriff, programme director for the Data for Research and Development Programme, describes some of the progress to date and describes the focus for the future.
Further information
The AAC supports all types of innovations: medicines, diagnostics, devices, digital products, pathway changes and new workforce models.
Final report of the independent review of UK commercial clinical trials, and government response.
Last edited: 2 December 2024 1:55 pm